AQST Stock Price
Aquestive Therapeutics, Inc.
AQST stock price is $4.66 (-0.32% on the day), giving Aquestive Therapeutics, Inc. a market cap of $586.14M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
AQST Stock Overview
- Price
- $4.66
- Previous close
- $4.67
- Open
- $4.73
- Market cap
- $586.14M
- P/E ratio
- -7.0
- 52-week range
- $2.93 - $7.55
- 1-year price target
- $9.22
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 50
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AQST | $4.66 | -0.3% | 886.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aquestive Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW